Skip to main content
Top
Published in: Internal and Emergency Medicine 1/2020

01-01-2020 | Empagliflozin | IM - CASE RECORD

Nephrotic range proteinuria and acute heart failure

Authors: Matteo Landolfo, Giulia Fiorini, Claudio Borghi

Published in: Internal and Emergency Medicine | Issue 1/2020

Login to get access

Excerpt

A 66-year-old woman with mild obesity, systemic hypertension and no history of previous treatment presented to our emergency department (ED) because of progressive exertional dyspnea and bilateral lower limbs swelling. At admission in the ED, arterial pressure was 188/86 mmHg, heart rate was 84 bpm and oxygen blood saturation was 96%. Physical examination confirmed bilateral symmetrical lower limbs pitting edema and bilateral rales at thoracic auscultation. Both laboratory and imaging findings were suggestive of acute decompensated heart failure (HF): BNP was 421 pg/mL and chest X-rays showed signs of congestion, mild pleural effusion and an enlarged cardiac shadow. Cardiac ultrasound revealed left ventricular concentric hypertrophy, mild left atrial enlargement and mild–moderate diastolic dysfunction (LVEF 60%, E/A 0.81, E/Eʹ 17, PAPS 30–40 mmHg). The patient was, thus, treated with intra-venous Furosemide and admitted to our Internal Medicine department with a diagnosis of “acute heart failure with preserved ejection fraction”. …
Literature
1.
go back to reference Gatta A, Verardo A, Bolognesi M (2012) Hypoalbuminemia. Intern Emerg Med 7(Suppl 3):S193–S199CrossRef Gatta A, Verardo A, Bolognesi M (2012) Hypoalbuminemia. Intern Emerg Med 7(Suppl 3):S193–S199CrossRef
2.
go back to reference Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M et al (2014) Hypoalbuminemia in acute heart failure patients: causes and its impact on hospital and long-term mortality. J Cardiac Fail 20:350–358CrossRef Bonilla-Palomas JL, Gamez-Lopez AL, Moreno-Conde M et al (2014) Hypoalbuminemia in acute heart failure patients: causes and its impact on hospital and long-term mortality. J Cardiac Fail 20:350–358CrossRef
3.
go back to reference Ancion A, Allepaerts S, Oury C et al (2017) Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail 4:138–145CrossRef Ancion A, Allepaerts S, Oury C et al (2017) Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail 4:138–145CrossRef
4.
go back to reference Liu M, Chan CP, Yan BP et al (2012) Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 14:39–44CrossRef Liu M, Chan CP, Yan BP et al (2012) Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 14:39–44CrossRef
5.
go back to reference Desai KV, Laine GA, Stewart RH et al (2008) Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 294:H2428–H2434CrossRef Desai KV, Laine GA, Stewart RH et al (2008) Mechanics of the left ventricular myocardial interstitium: effects of acute and chronic myocardial edema. Am J Physiol Heart Circ Physiol 294:H2428–H2434CrossRef
6.
go back to reference Svenningsen P, Friis UG, Versland JB et al (2013) Mechanisms of renal NaCl retention in proteinuric disease. Acta Physiol 207:536–545CrossRef Svenningsen P, Friis UG, Versland JB et al (2013) Mechanisms of renal NaCl retention in proteinuric disease. Acta Physiol 207:536–545CrossRef
7.
go back to reference Nakayama H, Koyama S, Kuragaichi T et al (2016) Prognostic value of rising serum albumin during hospitalization in patients with acute heart failure. Am J Cardiol 117:1305–1309CrossRef Nakayama H, Koyama S, Kuragaichi T et al (2016) Prognostic value of rising serum albumin during hospitalization in patients with acute heart failure. Am J Cardiol 117:1305–1309CrossRef
8.
go back to reference Finfer S, Bellomo R, McEvoy S et al (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333:1044CrossRef Finfer S, Bellomo R, McEvoy S et al (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333:1044CrossRef
9.
go back to reference Vincent JL, Dubois MJ, Navickis RJ et al (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A metanalysis of cohort studies and controlled trials. Ann Surg 237:319–334PubMedPubMedCentral Vincent JL, Dubois MJ, Navickis RJ et al (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A metanalysis of cohort studies and controlled trials. Ann Surg 237:319–334PubMedPubMedCentral
10.
go back to reference Martin GS, Moss M, Wheeler AP et al (2005) A randomized, controlled trial of furosemide with or without albumin in hypoproteinemia patients with acute lung injury. Crit Care Med 33:1681–1687CrossRef Martin GS, Moss M, Wheeler AP et al (2005) A randomized, controlled trial of furosemide with or without albumin in hypoproteinemia patients with acute lung injury. Crit Care Med 33:1681–1687CrossRef
11.
go back to reference Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355(9200):253–259CrossRef Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355(9200):253–259CrossRef
12.
go back to reference Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128CrossRef Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128CrossRef
13.
15.
go back to reference Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37:2129–2200CrossRef Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37:2129–2200CrossRef
Metadata
Title
Nephrotic range proteinuria and acute heart failure
Authors
Matteo Landolfo
Giulia Fiorini
Claudio Borghi
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02029-z

Other articles of this Issue 1/2020

Internal and Emergency Medicine 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.